Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

Abstract. Although next-generation sequencing (NGS) has helped characterize the complex genomic landscape of myeloid malignancies, its clinical utility remains undefined. This has resulted in variable funding for NGS testing, limiting its accessibility. At our center, targeted sequencing (TAR-SEQ) u...

Full description

Bibliographic Details
Main Authors: Waleed Alduaij, Caroline J. McNamara, Andre Schuh, Andrea Arruda, Mahadeo Sukhai, Nisha Kanwar, Mariam Thomas, Jay Spiegel, James A. Kennedy, Tracy Stockley, Hubert Tsui, Rebecca Devlin, Hassan Sibai, Dawn Maze, Aaron Schimmer, Karen Yee, Steven Chan, Suzanne Kamel-Reid, Vikas Gupta
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000044

Internet

http://journals.lww.com/10.1097/HS9.0000000000000044

Similar Items